Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Launches PlantX Shop to Complement, Expand E-Commerce Capabilities

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of PlantX Shop, the company’s new mobile application designed to enhance customer engagement and satisfaction by enabling a faster, simpler and more interactive shopping experience. The app, which aims to complement and expand the company’s existing e-commerce capabilities, will be available to all PlantX customers on iOS and Android mobile devices in Canada and the United States. “The new PlantX app offers us a truly exciting advantage in interacting with our community in more efficient and dynamic ways,” said PlantX CEO Lorne Rapkin. “There are many research studies that highlight the power of mobile technology in expanding business in the e-commerce space. Approximately one-third of online shopping is done through mobile apps, accounting for roughly 70% of all e-commerce sales. We are excited to see the potential of our new mobile app.”

To view the full press release, visit https://ibn.fm/vnI0P

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com and its YouTube channel.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in PlantX Life Inc. PLTXF | Leave a comment

As Older Population Starts Self-Directed Investing, O&G Company Engages SRAX Inc. (NASDAQ: SRAX) for Targeted Outreach

  • Charles Schwab survey shows 15% of retail investors started during the COVID-19 pandemic in 2020
  • SRAX’s Sequire premier IR communications platform assists public companies understand and communicate with the investment community
  • After following SRAX to understand its expertise, Sino American Oil Company has engaged SRAX
  • More than 250 companies now use Sequire, driving revenue to $8.3 million in Q3 and on the way to the high-end of 2021 guidance

The coronavirus pandemic changed many things in the world, and you can be sure investing is on the list. According to a Charles Schwab survey earlier this year, about 15 percent of today’s retail investor population got started in 2020, a group Schwab has labeled “Generation Investor.” In the survey of about 1,000 people, Schwab also learned that investing respondents are taking a long approach and that it isn’t just younger generations putting their money in the market, a mix that bodes well for communications specialists like SRAX (NASDAQ: SRAX).

SRAX is a diversified financial technology, digital marketing and consumer data management company that provides an array of consumer data to its clients valuable to marketing and communications. SRAX’s flagship offering is a premier investor intelligence and communications platform branded Sequire. In September 2020, SRAX also completed the acquisition of LD Micro, arguably the best-known name in data and events serving the small and microcap markets.

Schwab’s research discovered a median age of 35 for Generation Investor, comprised of about 11% Baby Boomers, 16% Generation Z, 22% Generations X and the remainder being Millennials. SRAX’s technology unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools, and data-driven marketing.

Looking to leverage the SRAX technology to assist with its investor outreach and growth initiatives, oil and gas explorer, Sino American Oil Company (OTCPK: OILY), engaged SRAX this month to better understand its investors and target them in an efficient manner. The partnership will allow Sino American Oil to optimize marketing and communications strategies to reach out to consumers, shareholders, and investors. 

According to Sino American Oil CEO Kim Halvorson, the company did its due diligence before partnering with SRAX. “We have been following SRAX for some time now, they’re expertise in the Oil and Gas sector and the digital marketing has been impressive,” said Halvorson.

Expanding its offerings, SRAX recently launched an IR Website Builder, SMS feature and VIRA, and an IR chatbot. This has translated to a strong improvement in revenue, which rose 219% year-over-year in the third quarter to $8.3 million. With Q4 bookings exceeding $12.5 million so far, SRAX is on track to hit the high end of 2021 guidance, according to CEO Christopher Miglino.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Tingo Inc. (IWBB), Data Vault Holdings Inc. Collaborate to Deliver Data Revenue to 10M Users Throughout Nigeria

Data Vault Holdings, leading the way in tokenomics and metaverse data visualization, valuation and monetization, today announced that 10 million users will be added to the Datavault(R) platform via its partnership with Tingo (OTC: IWBB), a leading agri-fintech business in Africa that has delivered significant impact with its unique rural communities-based business model. Per the update, the groundbreaking deal will provide 10 million users throughout Nigeria economic autonomy via data monetization with the cryptocurrency exchange CoinField. The deal represents a keystone partnership helping to build a data-backed cryptocurrency that will unleash the true economic power within Tingo’s user base. “I founded Tingo 20 years ago with the mission to bring technology to underserved communities in Nigeria,” said Dozy Mmobuosi, founder and CEO of Tingo. “My team and I are constantly looking to develop and deploy technology that will improve the lives and increase the income of people in rural communities in Nigeria and soon across Africa. The partnership with Datavault(R) is an important evolution in this journey and we are proud to lead the way with pioneering solutions that democratize access to key agricultural data points and allow our customers to monetize their data, increasing their household income. Innovations and partnerships like this pave the way for us to meet several of the UN Sustainable Development Goals, which we have adopted as our guiding principles.”

To view the full press release, visit https://ibn.fm/2qbFC

About Tingo Inc.

Tingo is a unique next-generation agri-fintech company offering, through Tingo Mobile in Nigeria, its wholly-owned subsidiary, Tingo’s device-as-a-service (“DaaS”)model that provides customers with personal communications services (“PCS”) using GSM technology for subscribers designed to meet the needs of individual consumers and businesses. Tingo Mobile has developed a comprehensive agri-fintech and agri-marketplace ecosystem to support almost 10 million customers within and outside the agricultural sector, becoming a leading provider in Africa of such services over the long term. Services offered include DaaS (smartphone leasing), agri-marketplace, airtime top ups, utilities payments, bill pay, access to insurance and lending services, collectively known as “NWASSA” and TingoPay, a comprehensive mobile wallet to support financial inclusion and deliver significant social impact in the agriculture sector supporting rural communities in line with UN SDG and ESG principles. For more information about the company, visit www.TingoInc.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Tingo Inc. IWBB | Leave a comment

Tingo, Inc. (IWBB) Seeks to Combine Commercial Success and Rural Community Empowerment

  • Tingo is an Africa-focused agri-fintech company, which seeks to empower rural farming communities through the introduction of innovative farming solutions
  • In addition to driving shareholder returns, the company has also sought to empower societies and produce social upliftment in rural communities in which it is active
  • The company has adopted 5 core sustainable development goals – food security, poverty alleviation, financial inclusion, employment opportunities, & gender equality

By the end of the first quarter of 2021, assets under management held within ESG (Environment, Social, Governance) focused funds around the world had ballooned to $1.984 trillion, driven by a global drive towards increased sustainability and rising social awareness. Soaring investor demand for assets aligning with their social and ethical concerns have turbo-charged inflows towards sustainable investments; in fact, a study found that 89 cents of every dollar invested within active funds in July 2021 was directed towards ESG-focused funds. Tingo (OTCQB: IWBB), a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa, has made it its mission to both, support the domestic economies of its host countries and support technological and financial inclusion to reduce poverty levels. Thus, and through its unique business model, Tingo hopes to deliver attractive returns to shareholders while simultaneously, investing in the long-term future of the company and its subsidiaries. 

Tingo Inc aims to be Africa’s leading agri-fintech player, with a multi-pronged strategy which seeks to provide a roadmap through which to address several key areas of social concern within the African continent. As such, the company has sought to adopt five core sustainable development goals as its corporate mission, namely – ensuring food security, driving poverty alleviation, promoting digital financial inclusion, encouraging job creation, and supporting female entrepreneurship and empowerment. 

A recent study found that nearly 72 percent of Nigerian smallholder farms survived on less than $1.90 per day, with most living well below the poverty line. Moreover, a significant percentage of the farmers were subject to the vagaries of climate change, an increasingly frequent challenge to the success of their individual harvests. Tingo has sought to both, alleviate poverty levels and address food security through the introduction of new and impactful agri-based farming solutions in a bid to create jobs and uplift incomes for millions of rural farmers in select markets.

Alongside their goal to boost employment opportunities within rural areas, Tingo has looked to alleviate poverty and promote digital financial inclusion amongst its millions of stake holders through the disruption of legacy micro-finance industries within the African region. The company has sought to provide its users with a range of innovative financial products, alongside an agri-trading platform and credit solutions, designed to helps farmers market their harvests in a more efficient manner and borrow funds at market rates. Farmers will now be able to access DeFi-stable coins and smart contracts, thereby providing agri-communities access to credit-market driven digital finance solutions to held make them more competitive. 

Through the company’s proprietary and proven digital technology platforms, Tingo will seek to provide low-cost and dignified mobile transaction services using a dedicated mobile application, thereby lifting a key business barrier to what has historically been a largely underbanked populace. 

A key tenet underpinning Tingo’s business model has been the company’s steadfast commitment to gender equality. Tingo has looked to encourage female entrepreneurship within Africa’s rural communities through the introduction of training schemes designed to encourage women to operate both, farming and collection businesses. The success of the scheme is best illustrated through Tingo’s burgeoning agent network, which currently consists of approximately 15,000 members – the overwhelming majority of whom are women (https://ibn.fm/qj4GM).

In a global economy which is increasingly seeing growing socio-economic differences and competitive pressures, Tingo Inc has sought to create a unique business model which seeks to build out the company as one of Africa’s leading agri-fintech providers while simultaneously, contributing to bettering the lives of millions with Africa’s rural communities.

For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Tingo Inc. IWBB | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals and Therapeutics

  • Around 40% of available marketed drugs are poorly bioavailable or soluble, and about 90% of New Chemical Entities are known for their low solubility and permeability
  • Lexaria’s patented DehydraTECH(TM) technology offers a solution by improving how APIs (active pharmaceutical ingredients) enter the bloodstream
  • DehydraTECH achieves this by bypassing first-pass-liver metabolism
  • By doing so, Lexaria is facilitating faster and much more thorough drug delivery 

In a report published in the Bioavailability Enhancement Technologies and Services Market, 2018-2030, it was established that around 40% of available marketed drugs are poorly bioavailable or soluble. It was further estimated that approximately 90% of New Chemical Entities (“NCEs”) belong to Biopharmaceutics Classification System (“BCS”) class II and IV, known for their low solubility and permeability (https://ibn.fm/xfrBh).

Today, a significant number of drugs fail to reach the market owing to their poor bioavailability. This has prompted companies to re-formulate existing product candidates and explore different tools and methods to try to solve the problem.

Lexaria Bioscience (NASDAQ: LEXX) has taken on the challenge and is currently leading the industry in terms of innovation in drug delivery platforms. Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (“APIs”) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules.

Lexaria’s DehydraTECH is a product of years of research and millions of dollars in investments. So far, the technology is covered by 23 issued and over 50 pending patents in 40 different countries worldwide.

The demand for solutions is so acute, that more and more companies are offering technologies and/or services geared towards bioavailability enhancement. In addition, several players have even developed novel, industry-leading technologies to maintain a competitive edge in this market that is showing great potential for growth. Lexaria recognized this opportunity back in 2014 and has been investing aggressively into research and the strategic partnerships it has forged so far.

Bioavailability can be described as how much an APIcan access the bloodstream within the body. This is typically dependent on absorption as well as secretion. It works on the principle that an API can only offer benefits if it can be absorbed into the body in the first place (https://ibn.fm/8DNGH).

One way through which drugs, particularly orally administered ones, have their bioavailability compromised is through first-pass liver processing. Usually, once they are ingested, they must travel from the intestine to the liver for metabolization, before they are circulated within the body and eventually to their targeted area. This arduous process can reduce the amount of drug that actually reaches the bloodstream by as much as twenty-fold inhibiting the effectiveness of the drug itself.

Because DehydraTECH bypasses this first-pass liver processing, the drugs begin to reach the bloodstream in as little as two minutes and often reach blood concentration levels between 100% and 200% higher. In addition, given the effectiveness of this technology, patients can also enjoy reduced drug dosing which has the potential to significantly lower the cost of treatment.

Lexaria remains committed to exploring new ways through which its DehydraTECH technology can help even more people. So far, it is investigating new products for hypertension, anti-viral treatments, oral nicotine, and other drug classes, with notable progress made so far. The company is also conducting research and development on several critical indications, including epilepsy, dementia, rheumatoid disease, diabetes, human hormones, Ibuprofen and Naproxen (“NSAIDs”), and PDE5 inhibitors.

Lexaria understands the value and usefulness of its technology, hence its commitment to further research and partnering with other strategic players within the industry. Its efforts improve the bioavailability of pharmaceuticals and therapeutics, one drug class at a time.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX.

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Follow-Up Study Results Confirming DehydraTECH(TM)-CBD Arterial Stiffness Reduction

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional results from its human clinical study HYPER-H21-2. The study was designed to evaluate the company’s proprietary DehydraTECH(TM)-processed cannabidiol (“CBD”) and its effectiveness in the treatment of hypertension. Results confirm the substance’s ability to reduce arterial stiffness and indicate potential broader applications beyond hypertension, including the treatment of cardiovascular and other diseases. According to the company, arterial stiffness can be a predictor of a variety of human diseases, including hypertension, diabetes mellitus, renal disease and more. A unique CBD formulation developed by Lexaria, DehydraTECH-CBD is based on the company’s patented and proprietary DehydraTECH drug-delivery technology. The company’s Human Study HYPER-H21-2 included 16 human volunteers aged 45 to 65 who received either a placebo or three separate doses of DehydraTECH-CBD over a 14-hour period then observed over a 24-hour period. “Reducing arterial stiffness in Lexaria’s recent hypertension study after only a single day of dosing with our DehydraTECH-CBD is a major discovery,” said Lexaria president John Docherty in the press release. “We know that increased arterial stiffness is correlated with many serious and life-threatening diseases affecting people worldwide, and we are optimistic that our latest findings could have future widespread implications for promotion of improved human health and wellness.”

To view the full press release, visit https://ibn.fm/rZMqY

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption of cannabinoids and nicotine by 5 to 10 times — and in some instances by as much as 27 times — compared to standard industry formulations, as well as reduce time of onset from one to two hours to minutes and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs and nonsteroidal, anti-inflammatory drugs (NSAIDs) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Moving Rapidly to Progress CYB003 Toward Clinical Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced a confirmed scientific advice meeting with the UK Medical and Healthcare Products Regulatory Agency (“MHRA”) for the first quarter of calendar year 2022. According to the update, this program milestone brings Cybin closer to advancing its lead investigational candidate CYB003 into clinical development for the treatment of major depressive disorder (“MDD”) and alcohol use disorder (“AUD”). “Encouraged by positive preclinical findings that demonstrated the advantages of our novel deuterated psilocybin analog over oral psilocybin for the treatment of mental health, we are moving rapidly to progress CYB003 toward clinical development,” said Doug Drysdale, CEO of Cybin. “We are looking forward to engaging with the MHRA to determine next steps for our clinical development path evaluating CYB003 for the treatment of MDD and AUD in the UK.”

To view the full press release, visit https://ibn.fm/KNpcO

About Cybin Inc.

Cybin is a leading ethical biopharmaceutical company working with a network of world-class partners and internationally recognized scientists on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focusing on Continued Growth of Top-Line Revenue, Bottom-Line Results

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has officially entered the second phase of a three-phase development strategy that captures its expansion plan in Florida after installing, commissioning and loading five of 30 planned modular grow pods, which are already growing plants. RWB, through its subsidiary Red White & Bloom Florida LLC (“RWBFL”), is fast-tracking the remaining 25 pods. Collectively, the 30 pods will provide about 19,000 square feet of operating space with an expected yield of 10,000 pounds of high-quality flower annually. RWB anticipates this annual yield will generate $30 million in additional revenue. RWBFL also successfully produced the first batch of chocolates from its new Sanderson production facility, announced in early September. A recent article reads, “The three-phased development strategy aligns perfectly with [RWB CEO Brad] Rogers’ summary of the company’s focus for the remainder of 2021 and throughout 2022. ‘The company will focus on the continued growth of our top-line revenue and bottom-line results through expansion of our house of brands that continue to gain momentum, fortification of our vertically integrated businesses and the synergies from our M&A success,’ stated Rogers.”

To view the full article, visit https://ibn.fm/oqQeg

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Florida, Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Red White & Bloom Brands Inc. RWBYF | Leave a comment

MissionIRNewsBreaks – Tingo Inc. (IWBB), Visa Partner to Drive Expansion Across Africa and Beyond

Tingo (OTCQB: IWBB), the leading agri-fintech in Africa, has partnered with Visa Inc. The partnership is intended to expand the company’s footprint across Africa as well as augment its business offerings across Nigeria by increasing financial services on Tingo’s platforms and driving their greater adoption, particularly digital payments. “With a shared vision to enable individuals, businesses and economies to thrive through financial services, Visa is expected to be a powerful lever to drive Tingo’s expansion across the African continent and beyond.,” a recent article reads. “But the partnership will not stop there. Committed to financial education, Tingo aims to increase financial literacy and greater economic independence across the continent, for which alliance with Visa will be crucial. Tingo and Visa will join forces to deliver knowledge and learning tools to empower communities with adequate information so that they can fully leverage the benefits of increased access to financial services.”

To view the full article, visit https://ibn.fm/41kaI

About Tingo Inc.

Tingo is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off-take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive microfinance solutions, empower societies, produce social upliftment in rural communities and open international opportunities. Additional information about the company can be found at www.TingoInc.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Tingo Inc. IWBB | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Positioned Amid Substantial Rise in Returns

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has seen a significant rise in its financial returns over the past year. “For the second quarter of fiscal 2021, the company reported Q2 revenues of $7.7 million, up 557% year-over-year, and rising by 41% quarter-on-quarter. The company also seized on the opportunity to update their corporate revenue guidance, increasing Q3 guidance to $8.3 million, which would represent at least a +7.7% quarter-on-quarter increase. SRAX also increased their full year revenue target to $32 million, up from $30 million previously,” reads a recent article. “Immediately following the second quarter earnings report, SRAX announced that they would be carrying out a simultaneous $10 million stock buy-back program as well as paying a one-time special dividend to its shareholders of record as of the 20th of September 2021. The special dividend, which would bear an approximate value of $0.23 per common share, would be in the form of an issuance of non-tradeable preferred shares, which would hold a notional value of approximately $6.5 million worth of Sequire’s clients’ stock. As the underlying shares are sold, the proceeds will be distributed to the preferred shareholders on a periodic basis.”

To view the full article, visit https://ibn.fm/jGNET

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and MySequire.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment